Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr., Tleyjeh IM, Rybak MJ, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015;132(15):1435-86. https://www.ncbi.nlm.nih.gov/pubmed/26373316
Beganovic M, Luther MK, Rice LB, Arias CA, Rybak MJ, LaPlante KL. A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis. Clin Infect Dis 2018;67(2):303-9. https://www.ncbi.nlm.nih.gov/pubmed/29390132
Briggs S, Broom M, Duffy E, Everts R, Everts G, Lowe B, et al. Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis. J Antimicrob Chemother 2021;76(8):2168-71. https://www.ncbi.nlm.nih.gov/pubmed/33975351
Chirouze C, Athan E, Alla F, Chu VH, Ralph Corey G, Selton-Suty C, et al. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect 2013;19(12):1140-7. https://www.ncbi.nlm.nih.gov/pubmed/23517406
Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK, et al. Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome. Circulation 2013;127(17):1810-7. https://www.ncbi.nlm.nih.gov/pubmed/23543002
Fernandez-Hidalgo N, Almirante B, Gavalda J, Gurgui M, Pena C, de Alarcon A, et al. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. Clin Infect Dis 2013;56(9):1261-8. https://www.ncbi.nlm.nih.gov/pubmed/23392394
Freeman L, Milkovits A, McDaniel L, Everson N. Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis. Int J Antimicrob Agents 2022;59(3):106522. https://www.ncbi.nlm.nih.gov/pubmed/35038556
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36(44):3075-128. https://www.ncbi.nlm.nih.gov/pubmed/26320109
Herrera-Hidalgo L, de Alarcon A, Lopez-Cortes LE, Luque-Marquez R, Lopez-Cortes LF, Gutierrez-Valencia A, et al. Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs? Antimicrob Agents Chemother 2021;65(1). https://www.ncbi.nlm.nih.gov/pubmed/33046488
Koehler P, Jung N, Cornely OA, Rybniker J, Fatkenheuer G. Combination Antimicrobial Therapy for Enterococcus faecalis Infective Endocarditis. Clin Infect Dis 2019;69(5):900. https://www.ncbi.nlm.nih.gov/pubmed/30715308
Leone S, Noviello S, Esposito S. Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci. Infection 2016;44(3):273-81. https://www.ncbi.nlm.nih.gov/pubmed/26324294
Maher M, Jensen KJ, Lee D, Nix DE. Stability of Ampicillin in Normal Saline and Buffered Normal Saline. Int J Pharm Compd 2016;20(4):338-42. https://www.ncbi.nlm.nih.gov/pubmed/28333679
Peterson SC, Lau TTY, Ensom MHH. Combination of ceftriaxone and ampicillin for the treatment of enterococcal endocarditis: A qualitative systematic review. Ann Pharmacother 2017;51(6):496-503. https://www.ncbi.nlm.nih.gov/pubmed/28166656
Ramos-Martinez A, Pericas JM, Fernandez-Cruz A, Munoz P, Valerio M, Kestler M, et al. Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study. PLoS One 2020;15(8):e0237011. https://www.ncbi.nlm.nih.gov/pubmed/32745091
Suzuki H, Carlson JR, Matsumoto E. Treatment of Enterococcus faecalis infective endocarditis with penicillin G plus ceftriaxone. Infect Dis (Lond) 2020;52(2):135-8. https://www.ncbi.nlm.nih.gov/pubmed/31566044
Tritle BJ, Timbrook TT, Fisher MA, Spivak ES. Penicillin as a Potential Agent for Dual beta-Lactam Therapy for Enterococcal Endocarditis. Clin Infect Dis 2020;70(6):1263-4. https://www.ncbi.nlm.nih.gov/pubmed/31260045
